MPAA3
Sigma
Panorama® Antibody Microarray - MAPK and PKC Pathways Kit
Description
| Features and Benefits | • Accurate & robust protein expression profiling against 84 MAPK & PKC-pathways related proteins. • Suitable for use with Cy3/Cy5-based detection chemistries. • Proprietary slide treatment minimizes background staining. |
| Other Notes | Please note that featured antibody content is lot specific and is subject to change. |
| To view Panorama® array literature, visit www.sigma-aldrich.com/arrayliterature. | |
| Legal Information | Benzonase® Nuclease is manufactured by Merck KGaA and its affiliates. The technology is covered by US Patent 5,173,418 and EP Patent 0,229,866. Nycomed Pharma A/S (Denmark) claims worldwide patent rights to Benzonase® Nuclease, which are licensed exclusively to Merck KGaA, Darmstadt, Germany. Benzonase® is a registered trademark of Merck KGaA, Darmstadt, Germany. Cy is a trademark of Amersham Pharmacia Biotech, UK Ltd. quadriPERM is a registered trademark of Heraeus Instrument GmbH. TWEEN is a registered trademark of Uniqema, a business unit of ICI Americas Inc. |
| General description | Panorama Antibody Microarray -MAPK & PKC Pathways Kit is designed for studying protein expression in cell or tissue extracts. The antibody array contains 84 different antibodies each spotted in duplicate on a nitrocellulose-coated slide. The antibodies are specific for kinases and phosphatases of the MAPK and PKC pathways. |
| Panorama is a registered trademark of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co. |
Properties
| shipped in | wet ice |
| storage temp. | 2-8°C |
Safety
| Hazard Codes | C |
| Risk Statements | 34 |
| Safety Statements | 26-36/37/39-45 |
| RIDADR | UN 3316 9/PG 2 |






